MONEY! Alere Inc. has secured its final six-month exclusive option period on Miraculins' preeclampsia technology and will provide Miraculins a non-refundable fee
I hope this is substantial cash to keep the marketing and promotion of PreVu as high profile as possible. When those numbers start to roll out, then we should really see a big move in this stock. Also, let's hope Alere is buying time while negotiating to purchase the pre-eclampsia test, or maybe to buyout Miraculins in its entirety.
Always pleasantly surprised to log on to Stockhouse and see MOM at the top of the discussion board. It means news of some kind has hit the wire.
Today's news is good, but it will get much bigger than this, I'm sure.
GLTA.